Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies

DALLAS–(BUSINESS WIRE)–Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures with participation from Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Arch Ventures co-founder Robert Nelsen, Paris Hilton, Bold Capital, First Light Capital Group, Boost VC, Jazz Ventures, Builders VC, Green Sands Equity, Draper Associates, Charles Hoskinson, among others, bringing

Leave a Reply

Your email address will not be published. Required fields are marked *